ABSCI CORP Amortization of Intangible Assets
ABSCI CORP (ABSI) reported Amortization of Intangible Assets of $3.40 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-24.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-03-24
- ABSCI CORP amortization of intangible assets for the quarter ending 2023-12-31 was $900.00K, a 0.00% change year-over-year.
- ABSCI CORP amortization of intangible assets for the quarter ending 2023-09-30 was $800.00K, a 0.00% change year-over-year.
- ABSCI CORP amortization of intangible assets for the quarter ending 2023-06-30 was $800.00K, a 0.00% change year-over-year.
- ABSCI CORP amortization of intangible assets for the quarter ending 2023-03-31 was $800.00K, a 0.00% change year-over-year.
- ABSCI CORP amortization of intangible assets for fiscal 2025 was $3.40M, a 0.00% change from fiscal 2024.
- ABSCI CORP amortization of intangible assets for fiscal 2024 was $3.40M, a 0.00% change from fiscal 2023.
- ABSCI CORP amortization of intangible assets for fiscal 2023 was $3.40M, a 0.00% change from fiscal 2022.
- ABSCI CORP amortization of intangible assets for fiscal 2022 was $3.40M, a 61.90% increase from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|
| 2025-12-31 | $3.40M 10-K · filed 2026-03-24 | |||
| 2024-12-31 | $3.40M 10-K · filed 2026-03-24 | |||
| 2023-12-31 | $900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $1.70M derived: sum of 2 quarters · filed 2025-03-18 | $2.50M derived: sum of 3 quarters · filed 2025-03-18 | $3.40M 10-K · filed 2025-03-18 |
| 2023-09-30 | $800.00K 10-Q · filed 2023-11-14 | $1.60M derived: sum of 2 quarters · filed 2023-11-14 | $2.50M 10-Q · filed 2023-11-14 | $3.30M derived: sum of 4 quarters · filed 2024-03-21 |
| 2023-06-30 | $800.00K 10-Q · filed 2023-08-14 | $1.70M 10-Q · filed 2023-08-14 | $2.50M derived: sum of 3 quarters · filed 2024-03-21 | $3.30M derived: sum of 4 quarters · filed 2024-03-21 |
| 2023-03-31 | $800.00K 10-Q · filed 2023-05-15 | $1.70M derived: sum of 2 quarters · filed 2024-03-21 | $2.50M derived: sum of 3 quarters · filed 2024-03-21 | $3.30M derived: sum of 4 quarters · filed 2024-03-21 |
| 2022-12-31 | $900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $1.70M derived: sum of 2 quarters · filed 2024-03-21 | $2.50M derived: sum of 3 quarters · filed 2024-03-21 | $3.40M 10-K · filed 2024-03-21 |
| 2022-09-30 | $800.00K 10-Q · filed 2023-11-14 | $1.60M derived: sum of 2 quarters · filed 2023-11-14 | $2.50M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $800.00K 10-Q · filed 2023-08-14 | $1.70M 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | $800.00K 10-Q · filed 2023-05-15 | |||
| 2021-12-31 | $2.10M 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |